Pay in 4 interest-free payments of $27.45 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
also known as Olaparib or KU-59436
Infigratinib in patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: the PROOF 301 trial
Formula: C19H31Cl2N3O3
calcium/calmodulin-dependent protein kinase 1 and smooth muscle myosin light-chain kinase
N-dimethylcarbamate
BMS 777607 Catalog No.:M10897-2 also known as Olaparib orBMS 777607, also known as BMS 817378 and ASLAN 002, a Met tyrosine kinase inhibitor, is an inhibitor of MET tyrosine kinase with potential antineoplastic activity. MET tyrosine kinase inhibitor BMS 777607 binds to c Met protein, or hepatocyte growth factor receptor (HGFR), preventing binding of hepatocyte growth factor (HGF) and disrupting the MET signaling pathway; this agent may induce cell death in tumor cells expressing c Met. c Met, a receptor